Skip to content
Brand AI

Stelara

Request correction

Product brand

UnclaimedRead 2× by AI crawlers

STELARA® (ustekinumab) is a treatment option for psoriatic arthritis, plaque psoriasis, Crohn’s disease, and ulcerative colitis.

Last updated September 11, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

STELARA® (ustekinumab) is presented on its official site as a treatment option for adults with moderately to severely active Crohn’s disease, adults with moderately to severely active ulcerative colitis, and adults and children 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis.

Sources2 sources

  1. 1Crohn’s Disease, Ulcerative Colitis, PsO & PsA Treatment | STELARA® (ustekinumab)stelarainfo.com
  2. 2Stelarawikidata.org

Cite this profile: Cite the canonical profile. /brand-wiki/stelara · Editorial policy · How profiles are compiled